Background
==========

Premature ejaculation (PE) is one of the most common male sexual dysfunctions, with prevalence ranging from 3% to 30% according to different definitions \[[@b1-medscimonit-22-3588],[@b2-medscimonit-22-3588]\]. In general, PE is divided into lifelong PE (LPE) and acquired PE (APE) \[[@b3-medscimonit-22-3588]\]. The latest definition of LPE includes 3 points: (i) IELT\<1 minute; (ii) the inability to delay ejaculation; and (iii) negative personal consequences \[[@b4-medscimonit-22-3588]\].

Previous studies of twins and familial studies had proved the genetic predisposition in LPE \[[@b5-medscimonit-22-3588]--[@b7-medscimonit-22-3588]\]. A twins study in Finnish men indicated that 0.30 of the etiology was a result of hereditary effect \[[@b7-medscimonit-22-3588]\]. However, twins and familial studies did not clarify which genetic variant might explain the genetic effects in LPE. To explore this problem, genetic association studies may be a possible approach. The susceptibility to LPE was considered to be a polygenic pattern, such as those genes linked to the metabolism of serotonin (5-HT) and those related to the expression of serotonin transporter (5-HTT). The focus of genetic research on 5-HT has had a very strict theoretical basis. Firstly, various selective serotonin reuptake inhibitors (SSRIs) were successfully used in the treatment of PE, and dapoxetine became the first approved drug for PE treatment \[[@b8-medscimonit-22-3588],[@b9-medscimonit-22-3588]\]. Secondly, animal experiments also demonstrated the role of 5-HT in ejaculation \[[@b10-medscimonit-22-3588],[@b11-medscimonit-22-3588]\]. Decreased duration of intravaginal ejaculation latency time (IELT) was associated with decreased 5-HT or the dysfunction of different 5-HT receptors \[[@b12-medscimonit-22-3588]\]. Furthermore, SNPs located in genes encoding 5-HT receptors were also reported to play a role in IELT of patients with PE \[[@b13-medscimonit-22-3588]--[@b16-medscimonit-22-3588]\].

SLC6A4, which encodes 5-HTT, locates on chromosome 17q11.1--17q12 of the human genome \[[@b17-medscimonit-22-3588]\]. Three common polymorphisms were described: an ins/del in the promoter, called 5-HTTLPR; a variable number of tandem repeat (VNTR) in intron 2, called STin2; and a SNP polymorphism in the noncoding 3′-UTR. In fact, 5-HTTLPR has been studied thoroughly, but the effect and function of STin2 VNTR is not yet clear. It has been proved to include 10-repeat and 12-repeat alleles of a 16/17 bp element in all ethnicities, and the rare 9-repeat allele appears only in people of European or African descent \[[@b18-medscimonit-22-3588],[@b19-medscimonit-22-3588]\]. STin2 VNTR works as a transcriptional regulator, and the transcriptional activity is determined by the number of repeats, with the STin2.12 having the highest expression \[[@b20-medscimonit-22-3588],[@b21-medscimonit-22-3588]\]. Therefore, STin2 VNTR could affect the amount of 5-HTT. Many studies had linked VNTR with disorders such as depression, bipolar depression, and a predisposition to obsessive compulsive disorder \[[@b18-medscimonit-22-3588],[@b22-medscimonit-22-3588],[@b23-medscimonit-22-3588]\].

Although many studies have explored SLC6A4 and LPE \[[@b24-medscimonit-22-3588]--[@b28-medscimonit-22-3588]\], only 1 of them studied STin2 VNTR \[[@b27-medscimonit-22-3588]\], and there have been no such studies in Chinese populations. Considering the important role of the serotonergic system in ejaculatory function, we aimed to determine whether STin2 VNTR is related to LPE in China.

Material and Methods
====================

Subjects and assessments
------------------------

The current study was carried out between October 2012 and October 2015. Each participant was informed of the purpose of the study and signed the informed consent. The initial evaluation of each subject completed a detailed face-to-face interview by an andrologist, including a questionnaire and physical examination. LPE in our study was defined according to the definition of ISSM \[[@b4-medscimonit-22-3588]\]. Finally, 115 patients with LPE were recruited by referral from the Andrology Outpatient Clinic. At the same time, 101 controls without PE complaint were enrolled from the medical examination center.

Subjects had to meet the following inclusion criteria: (I) heterosexual male patient aged 20--60 years; (II) Han descent and speaking Chinese; (III) in a regular sexual relationship with 1 female partner for ≥6 months. None of the subjects had mental or other major medical diseases. None of the participants had received antidepressants or phosphodiesterase type 5 inhibitors before enrolling in the trial. Patients with a urinary infection or disorders of the nervous system were also excluded from the study. We obtained 2 ml of EDTA-anticoagulated peripheral blood samples from every participant. The study was approved by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University (No.20150047).

Genotyping
----------

Genomic DNA was extracted from peripheral blood using the Puregene DNA extraction kit (Qiagen, Hilden, Germany) following the manufacturer's protocol. Allelic-specific PCR was used to determine STin2 VNTR polymorphism. We designed a pair of primers using the Primer3 Software Online Program. Oligonucleotide primers were as follows: forward 5′-TGGCGAGATTTGACTTTTCTACC-3′ and reverse 5′-CTGAGCTTCATCAAGGGGAAC-3′ were used to amplify the STin2 VNTR region. A 20-μl mixture was ready for PCR amplification, including HotStarTaq buffer, 3.0 mM Mg^2+^, 0.3 mM dNTP, 0.1μM of primers, 1 U HotStarTaq polymerase (Qiagen, Inc.), and 1 μl template DNA. PCR conditions were as follows: 15 min of initial denaturation at 95°C; 11 cycles of 94ºC for 20 s and 62--0.5ºC per cycle for 40 s and 68ºC for 2 min; followed by 24 cycles of 20 s of denaturation at 94°C, 56ºC for 40 s and 2 min of extension at 68°C, and a final extension of 60 min at 60°C. After digestion, the products were analyzed on a 3730 DNA analyzer (ABI, California). Two technicians called genotypes independently by visual observation of peak sizes using GeneMapper 4.0.

Statistical analyses
--------------------

The participants were classified according to alleles and genotypes. For the quantitative data, results are expressed as mean ± standard deviation (SD) and a 2-tailed *t*-test was used. Chi-square and Fisher exact tests were used to compare the genotype proportions. After the normality and homoscedasticity test, analyses of variance (ANOVA) using IELT as a variate were performed to test differences between different genotypes. All statistical evaluations were performed with SPSS 17.0 (SPSS Inc., Chicago, United States) for Windows. *P*\<0.05 was considered statistically significant.

Results
=======

Demographic characteristics
---------------------------

Among 216 subjects who met the inclusion criteria, only 1 patient was excluded from the present study because of sample coagulation. Finally, there were 114 patients and 101 controls completing the study. Demographic characteristics are summarized in [Table 1](#t1-medscimonit-22-3588){ref-type="table"}. The patients and controls showed no significant difference in terms of any characteristic except age (35.3±7.8 *vs.* 31.7±8.1, *P*\<0.001). However, because LPE is assumed be lifelong, the difference did not affect the comparability of the 2 groups.

STin2 VNTR allelic and genotypic frequencies distribution
---------------------------------------------------------

STin2 VNTR allelic frequencies are shown in [Table 2](#t2-medscimonit-22-3588){ref-type="table"}. In our study, the most common allele was STin2.12 (patients: 82.5%, controls: 75.2%), and no significant difference was found between the 2 groups (*P*=0.182). The STin2.9/12 and STin2.9/9 genotypes were infrequent, so they were excluded from further analyses. The distribution of genotypes of patients and controls followed HWE. The results showed a significantly higher frequency of STin2.12/12 genotype in LPE patients than in controls (*P*=0.026). Interestingly, the less common STin2.9 allele was present in our study, which was found in people of European or African descent in previous studies.

Correlation between STin2 VNTR dominant models and the risk of PE
-----------------------------------------------------------------

[Table 3](#t3-medscimonit-22-3588){ref-type="table"} shows results of analyses under the 3 models: (I) dominant STin2. 12 model (STin2.12/12+STin2.12/10 *vs.* STin2.10/10), (II) dominant STin2.10 model (STin2.10/10+STin2.12/10 *vs.* STin2.12/12), and (III) codominant model (STin2.12/12 *vs.* STin2.12/10 *vs.* STin2.10/10). To investigate the association between the 3 models and the risk of PE, binary logistic regression models were fitted. In the codominant model, we found a significantly lower frequency of STin2.12/10 in the LPE patients (23.0% *vs.* 35.7%, OR=0.52, 95% CI=0.28--0.96), although the difference was not statistically significant (*P*=0.108). A statistically significant association of the dominant STin2.10 model of STin2 was observed. In this model, the combined frequency of STin2.10 carriers was significantly lower in patients with LPE when compared with controls (28.3% *vs.* 41.8%, OR=0.55, 95% CI=0.31--0.97, *P*=0.040).

Comparison of IELT of different STin2 VNTR genotypes in the LPE group
---------------------------------------------------------------------

The IELT distribution is shown in [Table 4](#t4-medscimonit-22-3588){ref-type="table"}. The mean IELTs were 22.68±11.41 s, 33.62±9.13 s, and 33.17±9.26 s for STin2.12/12, STin2.12/10, and STin2.10/10, respectively. After the normality and homoscedasticity test, ANOVA of IELT was performed. The results showed significant difference in patients with STin2.12/12 when compared to STin2.12/10 and STin2.10/10 genotypes (STin2.12/12 *vs.* STin2.12/10; *P*=0.001; STin2.12/12 *vs.* STin2.10/10; *P*=0.024). According to the STin2.10 dominant model, the IELT results of STin2.12/12 also showed a significant difference compared to STin2.12/10+ STin2.10/10 genotypes (*P*=0.001). The fold-increase of the mean IELT in the STin2.12/10 and STin2.10/10 genotypes compared to STin2.12/12 genotype was 1.48. These data indicate that STin2.10 carriers on average had nearly a 50% longer intravaginal ejaculation time compared to STin2.12 homozygous in this study.

Discussion
==========

Recently, polymorphisms in SLC6A4 have been increasingly associated with LPE, especially 5-HTTLPR polymorphism. But the other polymorphism in SLC6A4, STin2 VNTR, has received less attention.

Our study evaluated 114 patients and 101 controls for the relationship between STin2 VNTR and LPE. The allelic frequency of the STin2.12 was 0.825 in patients and 0.752 in controls, which showed no significant difference (*P*=0.067). There was a significant difference in STin2.12/12 genotype, which was more common in the LPE group (*P*=0.026). However, our results contradicted a previous study by Zuccarello et al. \[[@b27-medscimonit-22-3588]\], which showed no difference between these 2 groups in genotypic and allelic frequency. More studies and meta-analyses of STin2 VNTR polymorphisms in this field are needed.

We also found a significant association between LPE and STin2.10 in the dominant model. Our data demonstrate that STin2.12/10 and STin2.10/10 genotypes, which carry the lower transcriptional activity STin2.10 allele, were protective genotypes when compared with the STin2.12/12 genotype. One explanation may be that the STin2.10 allele is dominant to the STin2.12 allele.

A third major finding was that IELT in the patients group was associated with STin2 VNTR. STin2.10 allele carriers had a longer IELT than those with STin2.12/12 genotypes. This result is consistent with psychopharmacological results from studies on 5-HT neurotransmission. Animal studies have shown that decreased 5-HT level can accelerate the process of ejaculation \[[@b10-medscimonit-22-3588]\]. Evidence shows that the STin2.12 allele has higher transcriptional activity than the STin2.10 allele \[[@b29-medscimonit-22-3588]\]. Therefore, the men carrying the higher expressing allele homozygote STin2.12/12 could have more functioning 5-HTT, thus leading to lower 5-HT availability \[[@b18-medscimonit-22-3588]\]. Our results add to this knowledge.

The effect of STin2 VNTR on ejaculatory function may be quite complicated. On the one hand, gene frequencies of STin2 VNTR vary significantly among different races and ethnicities, and is more common in Japanese (0.997) than in African Americans (0.713) and white Americans (0.523) \[[@b30-medscimonit-22-3588]\]. Our sample size of participants, as well as the relative homogeneity of demographic and clinical characteristics, make our study distinct. On the other hand, the function of Stin2 VNTR is still not clear. It may have a synergistic effect together with other polymorphisms on ejaculation, such as 5-HTTLPR \[[@b31-medscimonit-22-3588]\]. Further research on gene--gene interaction effects in LPE are needed.

Regarding treatment of SSRIs in LPE, only 1 study found that therapeutic effects were related to both STin2 VNTR and 5-HTTLPR polymorphisms \[[@b32-medscimonit-22-3588]\]. The findings indicated STin2.12/12 genotype responded better to sertraline (*P*=0.001). We will plan to replicate the present study in this interesting field in the future.

Conclusions
===========

To the best of our knowledge, this is the first study to focus on the STin2 VNTR polymorphism in Chinese patients with LPE. Our present results indicate that STin2 VNTR polymorphism is related to LPE. In summary, men with at least 1 copy of STin2.10 allele were at lower risk of PE than men with other variant at this locus. The current study shows that the STin2 VNTR polymorphism is associated with IELTs of LPE. Patients with STin2.12/12 genotypes had significantly shorter IELT than men with other genotypes.
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###### 

Comparision of the demographic characteristics in PE and control group.

  Characteristics               PE group    Control group   t/χ^2^   *P* value[\*](#tfn2-medscimonit-22-3588){ref-type="table-fn"}
  ----------------------------- ----------- --------------- -------- -----------------------------------------------------------------
  Age, years                    35.3±7.8    31.7±8.1        16.135   \<0.001[\*\*\*](#tfn4-medscimonit-22-3588){ref-type="table-fn"}
  BMI, kg/m^2^                  22.1±2.1    21.6±1.9        1.576    0.116
  Duration of relation, years   10.7±5.1    9.4±5.3         1.832    0.068
  Smoking                       76 (66.7)   78 (77.2)       2.939    0.860
  Drinking                      62 (54.4)   52 (51.5)       0.181    0.671
  Marital status (merried)      99 (86.8)   92 (91.1)       0.974    0.324
  Educational level                                         7.718    0.052
   Primary school               9 (7.9)     11 (10.9)                
   Middle school                25 (21.9)   20 (19.8)                
   High school                  19 (16.7)   31 (30.7)                
   University                   61 (53.5)   39 (38.6)                
  Occupational status                                       --       0.064[\*\*](#tfn3-medscimonit-22-3588){ref-type="table-fn"}
   Workers                      22 (19.3)   27 (26.7)                
   Drivers                      10 (8.8)    5 (5.0)                  
   Farmers                      6 (5.3)     1 (1.0)                  
   Officials                    17 (14.9)   27 (26.7)                
   Businessmen                  15 (13.2)   11 (10.9)                
   Other occupations            44 (38.6)   30 (29.7)                
  Monthly income (RMB)                                      4.132    0.127
   \<1,000                      5 (4.4)     12 (11.9)                
   1,000--3,000                 49 (43.0)   40 (39.6)                
   \>3,000                      60 (52.6)   49 (48.5)                

Data were expressed as mean ± standard deviation (SD) or count (percentage), as appropriate. BMI -- body mass index; RMB -- Renminbi; PE -- premature ejaculation.

Difference between two subgroups was assessed by two-tailed *t*-test or Chi-square test, as appropriate.

Except results of Fisher exact test.

Significant difference compared with control.

###### 

Results of STin2 VNTR polymorphism in patients and control group.

                   PE group   Control group   *P* value[\*](#tfn6-medscimonit-22-3588){ref-type="table-fn"}          
  ---------------- ---------- --------------- --------------------------------------------------------------- ------ ---------------------------------------------------------------
  STin2 allele                                                                                                       0.182
   STin2.12        188        82.5            152                                                             75.2   0.067
   STin2.10        38         16.7            47                                                              23.3   0.086
   STin2.9         2          0.9             3                                                               1.5    0.669[\*\*](#tfn7-medscimonit-22-3588){ref-type="table-fn"}
  STin2 genotype                                                                                                     0.108[\*\*\*](#tfn8-medscimonit-22-3588){ref-type="table-fn"}
   STin2.12/12     81         71.1            57                                                              56.4   0.026[\#](#tfn9-medscimonit-22-3588){ref-type="table-fn"}
   STin2.12/10     26         22.8            35                                                              34.7   0.054
   STin2.10/10     6          5.3             6                                                               5.9    0.892
   STin2.9/12      0          0               3                                                               3.0    --
   STin2.9/9       1          0.9             0                                                               0      --

Data were expressed as count and frequency.

Difference between two subgroups was assessed by Chi-square test.

Except results of Fisher exact test.

STin2.9/12 and STin2.9/9 genotypes were excluded from analyses.

Significant difference compared with control.

###### 

Results of dominant models of the polymorphisms of the STin2 VNTR genotype.

  Dominant models     STin2 genotype   LPE group count (%)   Control group count (%)   OR (95% CI)   P value[\*](#tfn11-medscimonit-22-3588){ref-type="table-fn"}
  ------------------- ---------------- --------------------- ------------------------- ------------- --------------------------------------------------------------
  STin2.12 dominant   12/12 + 12/10    107 (94.7)            92 (93.9)                 1.00          0.799
  10/10               6 (5.3)          6 (6.1)               0.86 (0.27--2.76)                       
  STin2.10 dominant   12/12            81 (71.7)             57 (58.2)                 1.00          0.040[\*\*](#tfn12-medscimonit-22-3588){ref-type="table-fn"}
  12/10 + 10/10       32 (28.3)        41 (41.8)             0.55 (0.31--0.97)                       
  Codominant          12/12            81 (71.7)             57 (58.2)                 1.00          0.108
  12/10               26 (23.0)        35 (35.7)             0.52 (0.28--0.96)                       
  10/10               6 (5.3)          6 (6.1)               0.70 (0.22--2.29)                       

Data were expressed as count (percentage).

Difference between two subgroups was assessed by logistic regression analysis.

Statistical significant after logistic regression analyses.

OR -- odds ratio; CI -- confidence interval.

###### 

Comparision of intravaginal ejaculation latency time (IELT) of STin2 genotype in LPE group.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                         Count   Median IELT (second)   Geometric mean IELT (second)   Mean\                                                                                                                      95% CI of mean
                                                                                       IELT (second)                                                                                                              
  ---------------------- ------- ---------------------- ------------------------------ -------------------------------------------------------------------------------------------------------------------------- ----------------
  Genotype                                                                                                                                                                                                        

   STin2.12/12           81      22.00                  19.36                          22.68±11.41[\*\*](#tfn15-medscimonit-22-3588){ref-type="table-fn"},[\#](#tfn16-medscimonit-22-3588){ref-type="table-fn"}   20.16--25.20

   STin2.12/10           26      34.50                  32.10                          33.62±9.13[\#\#](#tfn17-medscimonit-22-3588){ref-type="table-fn"}                                                          29.93--37.31

   STin2.10/10           6       31.5                   32.26                          33.17±9.26[\#\#](#tfn17-medscimonit-22-3588){ref-type="table-fn"}                                                          23.45--42.89

  STin2.10 dominant                                                                                                                                                                                               

   STin2.12/12           81      22.00                  19.36                          22.68±11.41                                                                                                                20.16--25.20

   STin2.12/10 + 10/10   32      33.00                  32.13                          33.53±9.01[\#\#](#tfn17-medscimonit-22-3588){ref-type="table-fn"}                                                          30.28--36.78

   Sum                   113     25.00                  22.34                          25.75±11.82                                                                                                                23.55--27.95
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Difference between Mean IELT of subgroups was assessed by one-way ANOVA analysis.

Significant difference compared with STin2.12/10.

Significant difference compared with STin2.10/10.

Significant difference compared with STin2.12/12.

IELT -- intravaginal ejaculation latency time; CI -- confidence interval.
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